Severe Cognitive Dysfunction in a Patient with Polyendocrinopathy

 

 Buy Article Permissions and Reprints

Abstract

Background: Polyglandular Autoimmune syndromes (PGAs) or polyendocrinopathies are immune mediated multiple endocrine gland failure sometimes accompanied by nonendocrine autoimmune disorders with varieties of presentations.

Case report: We describe a case of a middle aged man with severe cognitive dysfunction, brain atrophy, adrenal insufficiency, hypothyroidism, renal failure, thrombocytopenia, and positive antiphospholipid antibodies, with significant renal and cognitive improvement after hormone replacement.

Conclusions: PGAs may present with a broad spectrum of manifestations related to different organs like nervous,renal,cardiac and hematopoietic systems, sometimes challenging both to physician and the patient.

References

• 1 Akcay MN, Tekin SB, Akcay G. Addisonian crisis due to adrenal gland metastasis in Hodgkin's disease.  Int J Clin Pract. 2003;  57 840-841
  PubMedGoogle Scholar
• 2 Alarcon-Segovia D, Sanchez-Guerrero J. Correction of thrombocytopenia with small dose aspirin in the primary antiphospholipid syndrome.  J Rheumatol. 1989;  16 1359-1361
  PubMedGoogle Scholar
• 3 Amoroso A, Del Porto F, Garzia P, Mariotti A, Addessi MA, Afeltra A. Primary antiphospholipid syndrome and cerebral atrophy: a rare association?.  Am J Med Sci. 1999a;  317 425-428
  CrossrefPubMedGoogle Scholar
• 4 Amoroso A, Mitterhofer AP, Ferri GM, Galluzzo S, Vadacca M, Afeltra A. Neurological involvement in antiphospholipid antibodies syndrome (APS).  Eur Rev Med Pharmacol Sci. 1999b;  3 205-209
  PubMedGoogle Scholar
• 5 Aumaitre O, Pouplard-Barthelaix A, Thieblot P, Dordain G, Moinade S. [Association of autoimmune dementia, Basedow's disease, and Gougerot-Sjogren syndrome].  Ann Med Interne (Paris). 1985;  136 470-473
  PubMedGoogle Scholar
• 6 Berneis K, Buitrago-Tellez C, Muller B, Keller U, Tsakiris DA. Antiphospholipid syndrome and endocrine damage: why bilateral adrenal thrombosis?.  Eur J Haematol. 2003;  71 299-302
  CrossrefPubMedGoogle Scholar
• 7 Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction.  Endocr Rev. 2002;  23 327-364
  CrossrefPubMedGoogle Scholar
• 8 Bober E, Kovanlikaya A, Buyukgebiz A. Primary antiphospholipid syndrome: an unusual cause of adrenal insufficiency.  Horm Res. 2001;  56 140-144
  CrossrefPubMedGoogle Scholar
• 9 Bono G, Fancellu R, Blandini F, Santoro G, Mauri M. Cognitive and affective status in mild hypothyroidism and interactions with L-thyroxine treatment.  Acta Neurol Scand. 2004;  110 59-66
  CrossrefPubMedGoogle Scholar
• 10 Challa S, Jebakumar A, George M, William RR. Haemorrhagic pseudocyst of the adrenal in an adult (a case report).  Australas Radiol. 1989;  33 402-403
  PubMedGoogle Scholar
• 11 Dubovik V, Faigon M, Feldon J, Michaelson DM. Decreased density of forebrain cholinergic neurons in experimental autoimmune dementia.  Neuroscience. 1993;  56 75-82
  CrossrefPubMedGoogle Scholar
• 12 Eilam D, Szechtman H, Faigon M, Dubovik V, Feldon J, Michaelson DM. Disintegration of the spatial organization of behavior in experimental autoimmune dementia.  Neuroscience. 1993;  56 83-91
  CrossrefPubMedGoogle Scholar
• 13 Espinosa G, Cervera R, Font J, Asherson RA. Adrenal involvement in the antiphospholipid syndrome.  Lupus. 2003a;  12 569-572
  CrossrefPubMedGoogle Scholar
• 14 Espinosa G, Santos E, Cervera R. et al . Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients.  Medicine (Baltimore). 2003b;  82 106-118
  CrossrefPubMedGoogle Scholar
• 15 Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinican.  J Psychiatr Res. 1975;  12 189-198
  CrossrefPubMedGoogle Scholar
• 16 Folstein MF, Whitehouse PJ. Cognitive impairment of Alzheimer disease.  Neurobehav Toxicol Teratol. 1983;  5 631-634
  PubMedGoogle Scholar
• 17 Gomez-Puerta JA, Cervera R, Calvo LM. et al . Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients.  Rheumatology (Oxford). 2005;  44 95-99
  CrossrefPubMedGoogle Scholar
• 18 Graner JL. Addison, pernicious anemia and adrenal insufficiency.  CMAJ. 1985;  133 855-857 , 880
  PubMedGoogle Scholar
• 19 Harper MA, Earnshaw BA. Combined adrenal and thyroid deficiency (Schmidt's syndrome) presenting as an acute psychosis.  Med J Aust. 1970;  1 546-545 , 48
  PubMedGoogle Scholar
• 20 Heinrich TW, Grahm G. Hypothyroidism Presenting as Psychosis: Myxedema Madness Revisited.  Prim Care Companion J Clin Psychiatry. 2003;  5 260-266
  CrossrefPubMedGoogle Scholar
• 21 Heller T, Bergholtz M, Martin F, Borck V. [Bilateral adrenal hemorrhage occurring two times in primary antiphospholipid syndrome (APS). Anticoagulation as treatment of hemorrhage].  Dtsch Med Wochenschr. 2002;  127 1695-1698
  Article in Thieme ConnectPubMedGoogle Scholar
• 22 Kalashnikova LA. [Primary antiphospholipid syndrome and cerebrovascular disturbances].  Zh Nevrol Psikhiatr Im SS Korsakova. 2005;  105 11-16
  PubMedGoogle Scholar
• 23 Kannan CR. Diseases of the adrenal cortex.  Dis Mon. 1988;  34 601-674
  PubMedGoogle Scholar
• 24 Klose M, Lange M, Kosteljanetz M, Poulsgaard L, Feldt-Rasmussen U. Adrenocortical insufficiency after pituitary surgery: an audit of the reliability of the conventional short synacthen test.  Clin Endocrinol (Oxf). 2005;  63 499-505
  CrossrefPubMedGoogle Scholar
• 25 Lam KY, Lo CY. Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital.  Clin Endocrinol (Oxf). 2002;  56 95-101
  CrossrefPubMedGoogle Scholar
• 26 Lee IT, Lin SY, Sheul WH. Mood disorder and secondary adrenal insufficiency after pituitary tumor operation and radiotherapy.  J Chin Med Assoc. 2003;  66 375-378
  PubMedGoogle Scholar
• 27 Lee SI, Jeon HS, Yoo WH. Reversible dementia in systemic lupus erythematosus without antiphospholipid antibodies or cerebral infarction.  Rheumatol Int. 2004;  24 305-308
  PubMedGoogle Scholar
• 28 Lindesay J. The concept of delirium.  Dement Geriatr Cogn Disord. 1999;  10 310-314
  CrossrefPubMedGoogle Scholar
• 29 Lopponen MK, Isoaho RE, Raiha IJ. et al . Undiagnosed diseases in patients with dementia-a potential target group for intervention.  Dement Geriatr Cogn Disord. 2004;  18 321-329
  CrossrefPubMedGoogle Scholar
• 30 Mackworth-Young C. Primary antiphospholipid syndrome: A distinct entity?.  Autoimmun Rev. 2006;  5 70-75
  CrossrefPubMedGoogle Scholar
• 31 Michaelson DM, Alroy G, Goldstein D, Chapman J, Feldon J. Characterization of an experimental autoimmune dementia model in the rat.  Ann N.Y. Acad Sci. 1991;  640 290-294
  PubMedGoogle Scholar
• 32 Michaelson DM, Dubovik V, Faigon M, Eilam D, Feldon J. Decreased density of forebrain cholinergic neurons and disintegration of the spatial organization of behavior in experimental autoimmune dementia (EAD).  Ann N.Y. Acad Sci. 1993;  695 244-248
  CrossrefPubMedGoogle Scholar
• 33 Moudouni SM, En-Nia I, Rioux-Leclercq N, Guille F, Lobel B. Solitary contralateral adrenal metastasis after nephrectomy for renal cell carcinoma.  Urol Int. 2002;  68 295-298
  CrossrefPubMedGoogle Scholar
• 34 Nabriski D, Ellis M, Ness-Abramof R, Shapiro M, Shenkman L. Autoimmune thyroid disease and antiphospholipid antibodies.  Am J Hematol. 2000;  64 7.75-3
  PubMedGoogle Scholar
• 35 Neufeld M, Maclaren N, Blizzard R. Autoimmune polyglandular syndromes.  Pediatr Ann. 1980;  9 154-162
  PubMedGoogle Scholar
• 36 Neufeld M, Maclaren NK, Blizzard RM. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes.  Medicine (Baltimore). 1981;  60 355-362
  PubMedGoogle Scholar
• 37 Opocher G, Mantero F. Adrenal complications of HIV infection.  Baillieres Clin Endocrinol Metab. 1994;  8 769-776
  CrossrefPubMedGoogle Scholar
• 38 Oron L, Dubovik V, Novitsky L, Eilam D, Michaelson DM. Animal model and in vitro studies of anti neurofilament antibodies mediated neurodegeneration in Alzheimer's disease.  J Neural Transm Suppl. 1997;  49 77-84
  PubMedGoogle Scholar
• 39 Presotto F, Fornasini F, Betterle C, Federspil G, Rossato M. Acute adrenal failure as the heralding symptom of primary antiphospholipid syndrome: report of a case and review of the literature.  Eur J Endocrinol. 2005;  153 507-514
  CrossrefPubMedGoogle Scholar
• 40 Ringkananon U, Khovidhunkit W, Vongthavaravat V, Sridama V, Lalitanantpong S, Snabboon T. Adrenal crisis due to bilateral adrenal hemorrhage in primary antiphospholipid syndrome.  J Med Assoc Thai. 2005;  88 534-537
  PubMedGoogle Scholar
• 41 Sanna G, Bertolaccini ML, Cuadrado MJ. et al . Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.  J Rheumatol. 2003;  30 985-992
  PubMedGoogle Scholar
• 42 Shenker Y, Skatrud JB. Adrenal insufficiency in critically ill patients.  Am J Respir Crit Care Med. 2001;  163 1520-1523
  PubMedGoogle Scholar
• 43 Tanne D, Hassin-Baer S. Neurologic manifestations of the antiphospholipid syndrome.  Curr Rheumatol Rep. 2001;  3 286-293
  PubMedGoogle Scholar
• 44 Tomei E, Francone A, Salabe GB, Diacinti D, Gentile F, De Martinis C. Magnetic resonance imaging (MRI) studies of brain atrophy in hypothyroidism.  Rays. 1988;  13 43-47
  PubMedGoogle Scholar
• 45 Topliss DJ, White EL, Stockigt JR. Significance of thyrotropin excess in untreated primary adrenal insufficiency.  J Clin Endocrinol Metab. 1980;  50 56-52
  PubMedGoogle Scholar
• 46 Werber EA, Chapman J, Arlazoroff A. Brainstem auditory evoked potentials in experimental autoimmune dementia.  Neurosci Lett. 1993;  151 234-236
  CrossrefPubMedGoogle Scholar

Correspondence

M. S. Dastjerdi

Isfahan Endocrine & Metabolism Research Center

Sedigheh Tahereh Medical Research Complex

Khorram Street

Isfahan

Iran

Phone: 0098/311/335 99 33

Fax: 0098/311/337/37 33

Email: siavash@med.mui.ac.ir